Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BOLIVAR GENERAL HOSPITAL, INC.

NPI: 1518957950 · BOLIVAR, TN 38008 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 10/26/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official PRESCOTT, TINA controls 17+ related entities in our dataset. Read more

$2.36M
Total Medicaid Paid
63,428
Total Claims
53,489
Beneficiaries
43
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPRESCOTT, TINA (PRESIDENT AND CEO)
NPI Enumeration Date10/26/2005

Related Entities

Other providers sharing the same authorized official: PRESCOTT, TINA

ProviderCityStateTotal Paid
JACKSON MADISON COUNTY GENERAL HOSPITAL JACKSON TN $46.51M
PATHWAYS OF TENNESSEE, INC. JACKSON TN $30.54M
DYERSBURG HEALTH DYERSBURG TN $13.19M
JACKSON-MADISON COUNTY GENERAL HOSPITAL JACKSON TN $12.97M
JACKSON-MADISON COUNTY GENERAL HOSPITAL JACKSON TN $7.37M
WT MEDICAL ASSOCIATES DYERSBURG TN $5.52M
WEST TENNESSEE HEALTHCARE HENRY COUNTY PARIS TN $4.47M
THERAPY & LEARNING CENTER INC JACKSON TN $4.19M
MARTIN HEALTH MARTIN TN $3.94M
MILAN GENERAL HOSPITAL, INC. MILAN TN $3.54M
CAMDEN GENERAL HOSPITAL, INC. CAMDEN TN $3.46M
PATHWAYS OF TENNESSEE, INC. JACKSON TN $3.30M
MARTIN HEALTH SOUTH FULTON TN $1.47M
LIFT THERAPY, INC. JACKSON TN $778K
JACKSON-MADISON COUNTY GENERAL HOSPITAL JACKSON TN $449K
WEST TENNESSEE HEALTHCARE HENRY COUNTY PARIS TN $136K
JACKSON-MADISON COUNTY GENERAL HOSPITAL JACKSON TN $108K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 14,696 $499K
2019 12,340 $430K
2020 7,067 $274K
2021 7,132 $285K
2022 9,275 $368K
2023 8,403 $303K
2024 4,515 $199K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 10,476 9,172 $1.03M
99284 Emergency department visit for the evaluation and management, high severity 5,188 4,438 $858K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,116 913 $165K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,210 1,107 $87K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1,695 1,606 $40K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 9,381 7,734 $37K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,915 3,160 $22K
80053 Comprehensive metabolic panel 6,042 4,992 $18K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,460 2,208 $16K
36415 Collection of venous blood by venipuncture 9,232 7,507 $12K
G0378 Hospital observation service, per hour 90 60 $12K
84484 1,333 1,057 $12K
71045 Radiologic examination, chest; single view 1,978 1,710 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 141 132 $5K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,443 1,168 $5K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 537 441 $4K
87430 1,067 957 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 166 140 $3K
80048 Basic metabolic panel (calcium, ionized) 877 754 $3K
70450 Computed tomography, head or brain; without contrast material 120 97 $2K
81001 2,896 2,494 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 144 96 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 205 132 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor 32 31 $2K
83605 170 146 $1K
83690 240 190 $812.39
83880 152 127 $747.00
96375 Therapeutic injection; each additional sequential IV push 131 102 $672.84
81025 205 186 $593.38
71046 Radiologic examination, chest; 2 views 137 104 $562.75
74176 Computed tomography, abdomen and pelvis; without contrast material 16 12 $546.56
87081 149 136 $445.98
87807 70 67 $272.14
83735 50 42 $159.12
80305 56 48 $139.24
80076 31 25 $93.54
80061 Lipid panel 48 31 $79.77
82150 18 15 $68.72
84100 34 29 $58.56
84550 20 12 $3.82
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 15 12 $0.00
A9270 Non-covered item or service 126 87 $0.00
84443 Thyroid stimulating hormone (TSH) 16 12 $0.00